Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluating antitumor activity of Escherichia coli purine nucleoside phosphorylase against head and neck patient‐derived xenografts

Cancer Reports(2022)10.1002/cnr2.1708Source: DataRank Database

Evaluating antitumor activity of Escherichia coli purine nucleoside phosphorylase against head and neck patient‐derived xenografts is a research paper published in Cancer Reports (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.16)OA: goldTopics (56)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Annette Ehrhardt ORCID,Bhagelu R. Achyut ORCID,Disha Joshi ORCID,Melissa Gilbert‐Ross ORCID,Chunzi Huang

Live enrichment

PubMed:36253876 PMC:PMC9939994 OpenAlex:https://openalex.org/W4306658748

National Cancer Institute

Grant: P30CA138292

National Institutes of Health

Grant: R01DE026941

National Institutes of Health

Grant: 5R01DE026941-02

Intratumoral generation of F-Ade to ablate low growth fraction HNSCC

National Institutes of Health

Grant: 5P30CA138292-11

Winship Cancer Institute Cancer Center Support Grant

I.M. Sechenov First Moscow State Medical University

Frederick National Laboratory for Cancer Research

Northwestern University

Winship Cancer Institute

FWCI

0.16

Citation Percentile

0.4%

Citation Trend

2024

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cnr2.1708

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cnr2.1708

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1708

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cnr2.1708

journalhttps://doi.org/10.1002/cnr2.1708

Fields of Study

Biochemical and Molecular ResearchVirus-based gene therapy researchCancer Research and Treatments0301 basic medicine0303 health sciences03 medical and health sciencesHumansPurine-Nucleoside PhosphorylaseEscherichia coliHeterograftsGenetic VectorsGenetic TherapyHead and Neck NeoplasmsAdenoviridae

MeSH Terms

AdenoviridaeEscherichia coliGenetic VectorsHead and Neck NeoplasmsHumansPurine-Nucleoside PhosphorylaseGenetic TherapyHeterografts

Keywords

Purine nucleoside phosphorylasePurineCancer researchProdrugNucleoside analogueFludarabineCytotoxicityNucleosideHead and neck cancerChemistryBiologyCancerEnzymeMedicineBiochemistryChemotherapyIn vitroInternal medicineGene transferHead And Neck Squamous Cell CarcinomaPatient-derived XenograftsTropism Modified Adenoviruspatient‐derived xenograftsGenetic VectorsNeoplasms. Tumors. Oncology. Including cancer and carcinogensOriginal ArticlesGenetic TherapyAdenoviridaePurine-Nucleoside PhosphorylaseHead and Neck NeoplasmsEscherichia coliHumansHeterograftsRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being